Literature DB >> 8093047

Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity.

H Nishina1, K Inageda, K Takahashi, S Hoshino, K Ikeda, T Katada.   

Abstract

An ecto-enzyme of NAD glycohydrolase induced by retinoic acid in human leukemic HL-60 cells is attributed to the molecule of leukocyte cell surface antigen CD38 (Kontani, K., et al. (1993) J. Biol. Chem. 268, 16895-16898). The cell surface antigen has an amino acid sequence homologous to Aplysia ADP-ribosyl cyclase that catalyzes the conversion of NAD to cyclic ADP-ribose with a calcium-mobilizing activity. A putative hyaluronate (HA)-binding motif which has recently been identified in CD44 antigen existed in the extracellular domain and intracellular amino terminus of CD38 antigen. CD38 antigen was indeed capable of binding to HA in a manner dependent on ionic strength. By contrast, no binding activity was found in Aplysia ADP-ribosyl cyclase. Thus CD38 antigen, like CD44 antigen characterized as a HA-receptor (or binding) protein, may function as an adhesion molecule.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8093047     DOI: 10.1006/bbrc.1994.2326

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay.

Authors:  Basil P Hubbard; David A Sinclair
Journal:  Methods Mol Biol       Date:  2013

2.  Identification of human plasma cells with a lamprey monoclonal antibody.

Authors:  Cuiling Yu; Yanling Liu; Justin Tze Ho Chan; Jiefei Tong; Zhihua Li; Mengyao Shi; Dariush Davani; Marion Parsons; Srijit Khan; Wei Zhan; Shuya Kyu; Eyal Grunebaum; Paolo Campisi; Evan J Propst; David L Jaye; Suzanne Trudel; Michael F Moran; Mario Ostrowski; Brantley R Herrin; F Eun-Hyung Lee; Ignacio Sanz; Max D Cooper; Götz Ra Ehrhardt
Journal:  JCI Insight       Date:  2016-03-17

3.  CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.

Authors:  Xiangning Bu; Jiro Kato; Julie A Hong; Maria J Merino; David S Schrump; Frances E Lund; Joel Moss
Journal:  Carcinogenesis       Date:  2018-02-09       Impact factor: 4.944

4.  Molecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38.

Authors:  A Augustin; H Muller-Steffner; F Schuber
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

5.  Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.

Authors:  John C Riches; Conor J O'Donovan; Sarah J Kingdon; Fabienne McClanahan; Andrew J Clear; Donna S Neuberg; Lillian Werner; Carlo M Croce; Alan G Ramsay; Laura Z Rassenti; Thomas J Kipps; John G Gribben
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

6.  Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.

Authors:  M E Mummert; M Mohamadzadeh; D I Mummert; N Mizumoto; A Takashima
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

Review 7.  Hyaluronic Acid: Known for Almost a Century, but Still in Vogue.

Authors:  Anna Lierova; Jitka Kasparova; Alzbeta Filipova; Jana Cizkova; Lenka Pekarova; Lucie Korecka; Nikola Mannova; Zuzana Bilkova; Zuzana Sinkorova
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

8.  PECAM1(+)/Sca1(+)/CD38(+) vascular cells transform into myofibroblast-like cells in skin wound repair.

Authors:  Julia Etich; Vera Bergmeier; Christian Frie; Sandra Kreft; Lena Bengestrate; Sabine Eming; Cornelia Mauch; Beate Eckes; Hikmet Ulus; Frances E Lund; Gunter Rappl; Hinrich Abken; Mats Paulsson; Bent Brachvogel
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

9.  CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.

Authors:  L Galibert; N Burdin; B de Saint-Vis; P Garrone; C Van Kooten; J Banchereau; F Rousset
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

Review 10.  CD38 in the age of COVID-19: a medical perspective.

Authors:  Alberto L Horenstein; Angelo C Faini; Fabio Malavasi
Journal:  Physiol Rev       Date:  2021-03-31       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.